Notch Signaling Regulates Immune Responses in Atherosclerosis

Atherosclerosis is a chronic autoimmune inflammatory disease that can cause coronary artery disease, stroke, peripheral artery disease, depending on which arteries are affected. At the beginning of atherosclerosis plasma lipoproteins accumulate in the sub-endothelial space. In response, monocytes mi...

Full description

Bibliographic Details
Main Authors: Vieceli Dalla Sega, F., Fortini, F., Aquila, G., Campo, G., Vaccarezza, Mauro, Rizzo, P.
Format: Journal Article
Language:English
Published: FRONTIERS MEDIA SA 2019
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/75819
_version_ 1848763559077478400
author Vieceli Dalla Sega, F.
Fortini, F.
Aquila, G.
Campo, G.
Vaccarezza, Mauro
Rizzo, P.
author_facet Vieceli Dalla Sega, F.
Fortini, F.
Aquila, G.
Campo, G.
Vaccarezza, Mauro
Rizzo, P.
author_sort Vieceli Dalla Sega, F.
building Curtin Institutional Repository
collection Online Access
description Atherosclerosis is a chronic autoimmune inflammatory disease that can cause coronary artery disease, stroke, peripheral artery disease, depending on which arteries are affected. At the beginning of atherosclerosis plasma lipoproteins accumulate in the sub-endothelial space. In response, monocytes migrate from the circulation through the endothelium into the intima where they differentiate into macrophages. These early events trigger a complex immune response that eventually involves many cellular subtypes of both innate and adaptive immunity. The Notch signaling pathway is an evolutionary conserved cell signaling system that mediates cell-to-cell communication. Recent studies have revealed that Notch modulate atherosclerosis by controlling macrophages polarization into M1 or M2 subtypes. Furthermore, it is known that Notch signaling controls differentiation and activity of T-helper and cytotoxic T-cells in inflammatory diseases. In this review, we will discuss the role of Notch in modulating immunity in the context of atherosclerosis and whether targeting Notch may represent a therapeutic strategy.
first_indexed 2025-11-14T11:05:23Z
format Journal Article
id curtin-20.500.11937-75819
institution Curtin University Malaysia
institution_category Local University
language English
last_indexed 2025-11-14T11:05:23Z
publishDate 2019
publisher FRONTIERS MEDIA SA
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-758192019-07-11T00:42:09Z Notch Signaling Regulates Immune Responses in Atherosclerosis Vieceli Dalla Sega, F. Fortini, F. Aquila, G. Campo, G. Vaccarezza, Mauro Rizzo, P. Science & Technology Life Sciences & Biomedicine Immunology atherosclerosis endothelial dysfunction Notch DII4 immunity M1 macrophages T cells GSI GAMMA-SECRETASE INHIBITORS IN-VIVO FUNCTION T-CELL FUNCTION DENDRITIC CELLS TH17 CELLS MACROPHAGE POLARIZATION SUPPRESSOR-CELLS RBP-J VASCULAR ENDOTHELIUM GATA3 EXPRESSION Atherosclerosis is a chronic autoimmune inflammatory disease that can cause coronary artery disease, stroke, peripheral artery disease, depending on which arteries are affected. At the beginning of atherosclerosis plasma lipoproteins accumulate in the sub-endothelial space. In response, monocytes migrate from the circulation through the endothelium into the intima where they differentiate into macrophages. These early events trigger a complex immune response that eventually involves many cellular subtypes of both innate and adaptive immunity. The Notch signaling pathway is an evolutionary conserved cell signaling system that mediates cell-to-cell communication. Recent studies have revealed that Notch modulate atherosclerosis by controlling macrophages polarization into M1 or M2 subtypes. Furthermore, it is known that Notch signaling controls differentiation and activity of T-helper and cytotoxic T-cells in inflammatory diseases. In this review, we will discuss the role of Notch in modulating immunity in the context of atherosclerosis and whether targeting Notch may represent a therapeutic strategy. 2019 Journal Article http://hdl.handle.net/20.500.11937/75819 10.3389/fimmu.2019.01130 English http://creativecommons.org/licenses/by/4.0/ FRONTIERS MEDIA SA fulltext
spellingShingle Science & Technology
Life Sciences & Biomedicine
Immunology
atherosclerosis
endothelial dysfunction
Notch
DII4
immunity
M1 macrophages
T cells
GSI
GAMMA-SECRETASE INHIBITORS
IN-VIVO FUNCTION
T-CELL FUNCTION
DENDRITIC CELLS
TH17 CELLS
MACROPHAGE POLARIZATION
SUPPRESSOR-CELLS
RBP-J
VASCULAR ENDOTHELIUM
GATA3 EXPRESSION
Vieceli Dalla Sega, F.
Fortini, F.
Aquila, G.
Campo, G.
Vaccarezza, Mauro
Rizzo, P.
Notch Signaling Regulates Immune Responses in Atherosclerosis
title Notch Signaling Regulates Immune Responses in Atherosclerosis
title_full Notch Signaling Regulates Immune Responses in Atherosclerosis
title_fullStr Notch Signaling Regulates Immune Responses in Atherosclerosis
title_full_unstemmed Notch Signaling Regulates Immune Responses in Atherosclerosis
title_short Notch Signaling Regulates Immune Responses in Atherosclerosis
title_sort notch signaling regulates immune responses in atherosclerosis
topic Science & Technology
Life Sciences & Biomedicine
Immunology
atherosclerosis
endothelial dysfunction
Notch
DII4
immunity
M1 macrophages
T cells
GSI
GAMMA-SECRETASE INHIBITORS
IN-VIVO FUNCTION
T-CELL FUNCTION
DENDRITIC CELLS
TH17 CELLS
MACROPHAGE POLARIZATION
SUPPRESSOR-CELLS
RBP-J
VASCULAR ENDOTHELIUM
GATA3 EXPRESSION
url http://hdl.handle.net/20.500.11937/75819